As of January 2025, Takeda Pharmaceutical Company has a market cap of $41.27B. This makes Takeda Pharmaceutical Company the world's 417th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $43.08B | 6.44% |
2023 | $40.47B | -1.39% |
2022 | $41.04B | 31.05% |
2021 | $31.32B | -16.46% |
2020 | $37.49B | -13.32% |
2019 | $43.25B | 16.92% |
2018 | $36.99B | -42.12% |
2017 | $63.90B | 32.39% |
2016 | $48.27B | -20.28% |
2015 | $60.55B | 21.38% |
2014 | $49.88B | 3.55% |
2013 | $48.17B | 25.16% |
2012 | $38.48B | 14.05% |
2011 | $33.74B | -15.39% |
2010 | $39.88B | 4.31% |
2009 | $38.24B | -17.46% |
2008 | $46.32B | -29.38% |
2007 | $65.59B | -19.58% |
2006 | $81.56B | 28.06% |
2005 | $63.69B | 23.64% |
2004 | $51.51B | 21.41% |
2003 | $42.43B | -14.31% |
2002 | $49.52B | -16.36% |
2001 | $59.20B | -12.28% |
2000 | $67.49B | - |